Medical Care Germany · Berlin
Advanced urological oncology — PSMA PET-CT, robotic surgery, radioligand therapy — coordinated at German university hospitals.
About the Condition
Prostate cancer management in Germany is conducted within certified prostate cancer centers that apply multidisciplinary tumor board review for all cases. German university urology departments offer the full spectrum of treatment options — from active surveillance for low-risk disease to radical prostatectomy, radiation therapy, and systemic therapies for advanced and metastatic disease.
Risk stratification based on PSA level, Gleason score, and clinical stage guides treatment decisions. PSMA PET-CT has become the standard staging tool in Germany for detecting nodal and distant metastases with higher sensitivity than conventional imaging, particularly in the context of biochemical recurrence.
Why Germany
German university urology centers perform robotic-assisted radical prostatectomy (RARP) with high surgical volume, associated with favourable functional and oncological outcomes. PSMA-targeted radioligand therapy is available at German nuclear medicine centers for eligible patients with metastatic castration-resistant prostate cancer, and focal therapy options including HIFU are offered at selected centers.
Specialist evaluation involves a review of PSA history, biopsy pathology, staging imaging including PSMA PET-CT, and prior treatment history. German urological oncologists assess whether the current risk stratification is accurate, determine the most appropriate primary or salvage treatment approach, and evaluate eligibility for systemic or radioligand therapies.
Treatment Pathways
Treatment selection in German prostate cancer centers is determined by a multidisciplinary tumor board — urologist, radiation oncologist, and medical oncologist reviewing each case together. The approach depends on PSA level, Gleason score, clinical stage, and patient preference.
Advanced Diagnostics
PSMA PET-CT has transformed prostate cancer staging in Germany. It detects nodal and distant metastases — including liver metastases — with significantly higher sensitivity than conventional CT or bone scan, particularly in cases of PSA recurrence after local treatment.
Advanced Disease
Liver metastases from prostate cancer (visceral metastatic disease) represent an advanced stage requiring a coordinated multidisciplinary approach. German university centers manage this with concurrent urological oncology, interventional radiology, and hepatobiliary surgery involvement.
Delivers chemotherapy directly to liver lesions via catheter
Highly precise radiation targeting individual liver metastases
Radiofrequency or microwave ablation — minimally invasive destruction of liver lesions under imaging
Centers of Excellence
We coordinate with certified prostate cancer centers (Prostatakarzinomzentrum) holding DKG or DGU certification — the highest quality standard in German oncology.
Department of Urology with full PSMA PET-CT, robotic surgery (da Vinci Xi), and radioligand therapy program.
Certified prostate cancer center with multidisciplinary tumor board and full urological oncology services.
Network of DKG-certified cancer centers across Germany with standardised prostate cancer protocols.
Academic urology department with active clinical trials and PSMA theranostics program.
Cost & Planning
Treatment costs depend on the clinical stage, chosen hospital, and treatment protocol. There is no single fixed price — costs are determined case by case following specialist review of your pathology and imaging.
We obtain a formal cost estimate from the hospital — at no charge to you. Send us your PSA history, biopsy report, and latest imaging. We submit to the relevant specialist and return with a detailed cost breakdown before any commitment.
Request Cost Estimate — FreeQuestions
Related